Golam Mohi, PhD (IMAGE)

University of Virginia Health System

Golam Mohi, PhD

Caption

A discovery by UVA School of Medicine researcher Golam Mohi, PhD, shows that a drug used to treat certain advanced breast cancers may offer a new treatment option for a deadly blood cancer known as myelofibrosis.

Credit

UVA Health

Usage Restrictions

May be used with coverage of this release only.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.